{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Catalyst Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"CPRX"},"Address":{"label":"Address","value":"355 ALHAMBRA CIRCLE,SUITE 801, CORAL GABLES, Florida, 33134, United States"},"Phone":{"label":"Phone","value":"+1 305 420-3200"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome."},"CompanyUrl":{"label":"Company Url","value":"https://www.catalystpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Gary Ingenito","title":"Chief Medical & Regulatory Officer"},{"name":"Richard John Daly","title":"President, Chief Executive Officer & Director"},{"name":"Stanley Iyadurai","title":"Senior VP-Medical Affairs & Drug Discovery"},{"name":"Steven R. Miller","title":"Chief Operating & Scientific Officer, Executive VP"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}